CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Risk of anaphylactic reaction associated with glatiramer… recall

Risk of anaphylactic reaction associated with glatiramer acetate, used to treat multiple sclerosis

Read the official Health Canada notice

Published
21 Aug 2025
Agency
Health Canada
Country
Canada

The hazard

Product safety - New safety information

What to do

If you experience anaphylactic reaction symptoms, stop taking glatiramer acetate and seek immediate medical help by calling 9-1-1.Do not restart taking glatiramer acetate if you have experienced anaphylaxis unless your healthcare provider has identified another clear cause for the anaphylaxis. Report any health product-related side effects to Health Canada. What healthcare professionals should doInform patients and/or caregivers of the signs and symptoms of anaphylactic reactions, which may overlap with those of an immediate post-injection reaction. Instruct patients to seek immediate emergency medical care in the event of an anaphylactic reaction. Instruct patients to discontinue treatment with glatiramer acetate if they have an anaphylactic reaction. Do not restart the medicine unless there is another clear reason the patient experienced an anaphylactic reaction.

  • Stop using the product until you have checked whether yours is affected.
  • Compare model numbers, batch codes and dates on the label with the official notice.
  • Contact the company in the notice for your refund, repair or replacement. Do not sell or give it away.
Read the official Health Canada notice

Source: Health Canada, published 21 Aug 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.